Form 8-K · Current report
News Corp 8-K, filed Sep 15, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000201
Summary
News Corp filed a Form 8-K disclosing daily buy-back notifications to the Australian Securities Exchange under its 2025 Repurchase Program, which authorizes up to US$1 billion of its Nasdaq-listed Class A and Class B common stock. The company bought back 54,641 shares on 14 September 2026 and reports approximately US$476 million of purchases under the program to date.
Key points
- News Corp repurchased 54,641 shares on 14 September 2026 for about US$1.66 million, bringing cumulative buy-backs to 11,903,378 shares for about US$309.8 million.
- About US$476 million of the authorized US$1 billion has been used under the 2025 Repurchase Program.
- The program, authorized as of 15 July 2025, covers Nasdaq-listed Class A and Class B common stock; no ASX-listed CDIs are being repurchased.
- Goldman Sachs & Co. LLC is named as broker for the buy-backs.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.